BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22419041)

  • 1. KLOTHO methylation is linked to uremic toxins and chronic kidney disease.
    Young GH; Wu VC
    Kidney Int; 2012 Apr; 81(7):611-2. PubMed ID: 22419041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
    Ritter CS; Zhang S; Delmez J; Finch JL; Slatopolsky E
    Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho: an antiaging protein involved in mineral and vitamin D metabolism.
    Torres PU; Prié D; Molina-Blétry V; Beck L; Silve C; Friedlander G
    Kidney Int; 2007 Apr; 71(8):730-7. PubMed ID: 17332731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotho and chronic kidney disease.
    Hu MC; Kuro-o M; Moe OW
    Contrib Nephrol; 2013; 180():47-63. PubMed ID: 23652549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathologies of calcium-phosphate homeostasis].
    Karczmarewicz E; Czekuć-Kryskiewicz E; Lorenc RS
    Postepy Biochem; 2012; 58(4):474-7. PubMed ID: 23662440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
    Drüeke TB
    Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.
    Sun CY; Chang SC; Wu MS
    Kidney Int; 2012 Apr; 81(7):640-50. PubMed ID: 22237753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
    Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
    Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
    Xie J; Wu YL; Huang CL
    Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism.
    Ohkido I; Yokoyama K; Imura A; Utsunomiya Y; Hosoya T; Nabeshima Y
    Nephrol Dial Transplant; 2010 Mar; 25(3):1007-8; author reply 1008-9. PubMed ID: 20075437
    [No Abstract]   [Full Text] [Related]  

  • 17. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
    Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
    Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A potential link between phosphate and aging].
    Shiizaki K; Kuro-o M
    Clin Calcium; 2012 Oct; 22(10):1493-8. PubMed ID: 23023628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
    Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.
    Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M
    FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.